Marketplace Pharmaceuticals

Contracting Office Address Department of Health and Human Services, Office of Acquisition Grants Services, 5630 Fishers Lane, Rockville MD, 20877 Description The Food and Drug Administration is soliciting for marketplace pharmaceuticals. (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals/bids are being requested and a written solicitation will not be issued. This action is for a small business set aside. (ii) The solicitation number is, 12-223-SOL-00141. This solicitation is issued as a Request for Quote (RFQ). (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) FAC 2005-58, effective May 18, 2012. (iv) This is a firm fixed price requirement. All responsible sources may submit a quote which shall be considered. The associated North American Industry Classification System (NAICS) Code is 424210. Deliverables: - Intron-A 50 MIU powder, 0.192 mg X 40 vials (multiple lots) - Estimated Shipping and handling An official authorized to bind the Offeror must sign the terms and conditions of the offer. Offerors that fail to finish required representations, or reject the terms and conditions of the solicitation, may be excluded from consideration. FOB Point Destination, with services on-site. Contract type: Commercial Item-Firm Fixed Price. Simplified procurement procedures will be utilized. (vi) The period of performance: Delivery is required 30 days after receipt of order (ARO). FOB Point of Delivery for Services and Supplies provided will be the Food and Drug Administration, 1114 Market Street, RM1002, St. Louis, MO 63101 (vii) The provision at FAR 52.212-1 Instructions to Offerors- Commercial Items applies to this solicitation. The following addenda have been attached to this provision: None. (viii) The government is not responsible for locating or securing any information, which is not identified in the submission. To ensure sufficient information is available, vendors must furnish as part of their proposal all descriptive material (such as cuts, illustration, drawings, or other information) necessary for the government to determine whether the product meets their requirements. (ix) Offerors must include a completed copy of the provision at FAR 52.212-3, Offeror Representations and Certifications- Commercial Items with its offer. (x) The clause at 52.212-4, Contract Terms and Conditions- Commercial Items, applies to this acquisition. The following addenda have been attached to the clause: None. (xi) The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes of Executive Orders-Commercial Items, applies to this acquisition. The following additional FAR clauses cited in this clause are applicable: 52.219-6, 52.222-3, 52.222-19, 52.222-21, 52.222-26, 52.222-35, 52.222-37, 52.225-1, 52.225-3, 52.225-13, and 52.232-33. Clauses and provisions are incorporated by reference and apply to this acquisition. Clauses and provisions can be obtained at http://www.acquisition.gov. CCR Requirement-Company must be registered on Central Contractor Registration (CCR) before an award could be made to them. If company is not registered in CCR, they may do so by going to CCR web site at http://www.ccr.gov. (xii) A standard commercial warranty on parts and workmanship is required. (xiii) The Defense Priorities and Allocations System and assigned rating are not applicable to this solicitation notice. (xiv) Applicable Numbered Note(s) None. (xv) Offers are due in person, by mail, e-mail or fax on or before June 21, 2012 by 15:00 hours (Eastern Standard Time), at Food and Drug Administration SCC/DASG/OAGS/HFA-500, Attn: Allison Mlawsky, 5630 Fishers Lane, Rockville MD, 20857. ph (301)827-9348 fax (301)827-7101 email: Allison.mlawsky@fda.hhs.gov. (xvi) For information regarding this solicitation, please contact Allison Mlawsky @ (301)827-9348, fax, (301)827-7101, email Allison.mlawsky@fda.hhs.gov. Point(s) of Contact - Allison Mlawsky, Contract Specialist, Phone (301)827-9348, fax (301)827-7101, e-mail Allison.mlawsky@fda.hhs.gov - Tania Gates, (301) 827-7176, fax (301)827-7101, e-mail: Tania.gates@fda.hhs.gov. Place of Performance Food & Drug Administration 1114 Market St. RM1002 St. Louis, MO 63101